<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00412048</url>
  </required_header>
  <id_info>
    <org_study_id>3659</org_study_id>
    <nct_id>NCT00412048</nct_id>
  </id_info>
  <brief_title>Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease</brief_title>
  <official_title>Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the protocol is to study the resting brain activation profile of 3 groups of
      people, using a new fMRI procedure, called fMRI-SAM. fMRI-SAM will be applied to 25
      Alzheimer's disease (AD) patients, 25 patients suffering from amnestic - mild cognitive
      impairment (MCI) - a clinical picture which may be a prodromal form of AD - and 60 healthy
      controls. The first analysis of the data will search differences of brain activation profiles
      between the 3 groups. In the second step, the investigators will study the predictive value
      of fMRI-SAM to detect MCI patients who will later convert to AD.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparing fMRI data between 3 groups of subjects: MCI, Alzheimer's disease and normal subjects</measure>
    <time_frame>1, 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Follow-up of MCI patients at 6, 12 and 18 months to detect a conversion to Alzheimer's disease</measure>
    <time_frame>Prediction of Alzheimer's disease on fMRI data</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>ALZHEIMER DISEASE</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MOLD COGNITIVE IMPAIRMENT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROLS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fMRI to detect MCI patients who will convert to Alzheimer's disease</intervention_name>
    <description>There is a fMRI to be realized in the 3 arms. No drug is administered</description>
    <arm_group_label>ALZHEIMER DISEASE</arm_group_label>
    <arm_group_label>MOLD COGNITIVE IMPAIRMENT</arm_group_label>
    <arm_group_label>CONTROLS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Alzheimer's disease of mild to moderate severity (25 patients)

          -  Amnestic MCI patients (25 patients)

          -  55-75 year-old patients

        Exclusion criteria:

          -  Any other cause of dementia for AD patients

          -  Any stroke

          -  Any disease with a negative vital prognosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois Sellal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HÃ´pitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2006</study_first_submitted>
  <study_first_submitted_qc>December 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2006</study_first_posted>
  <last_update_submitted>November 12, 2012</last_update_submitted>
  <last_update_submitted_qc>November 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

